Tandem Diabetes Care, Inc. cash flow to debt ratio of -2.19% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Tandem Diabetes Care, Inc.'s free cash flow has decreased 694.09% from $4.99M last year to $-29.67M, signaling decreasing performance

Tandem Diabetes Care, Inc.'s debt to equity ratio is 5.67, which means that the company's assets are unhealthy financed, signaling financial risk.

Tandem Diabetes Care, Inc.'s debt has increased relative to shareholder equity from 1.80 last year to 5.67 today, signaling weakened financials

Tandem Diabetes Care, Inc. has negative EBITDA, making leverage ratio unreliable

Tandem Diabetes Care, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Tandem Diabetes Care, Inc.'s profit margin has increased (-40.47%) in the last year from -10.21% to -6.08%, signaling increasing performance

Tandem Diabetes Care, Inc.'s short-term assets of $618.14M exceed its short-term liabilities of $242.72M

Tandem Diabetes Care, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Tandem Diabetes Care, Inc.'s return on equity of -45.97%, is lower than 15.00%, indicating bad performance

Tandem Diabetes Care, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Tandem Diabetes Care, Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Tandem Diabetes Care, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Tandem Diabetes Care, Inc. has negative free cash flow, indicating cash burn

Tandem Diabetes Care, Inc.'s yearly earnings has decreased 113.18% since last year from $-96.03M to $-204.71M, signaling decreasing performance

Tandem Diabetes Care, Inc.'s yearly revenue has increased 7.93% since last year from $940.20M to $1.01B, signaling increasing performance

ROIC -4.67% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Tandem Diabetes Care, Inc.'s 3-year revenue CAGR of 8.19% is positive, indicating growing revenue over the past 3 years

Tandem Diabetes Care, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Tandem Diabetes Care, Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Tandem Diabetes Care, Inc. has insufficient data to evaluate this check.

Tandem Diabetes Care, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tandem Diabetes Care, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Tandem Diabetes Care, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Tandem Diabetes Care, Inc. is overvalued relative to its fair value price of -30.78 based on Earnings Fair Value model

Tandem Diabetes Care, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Tandem Diabetes Care, Inc. has a price-to-book ratio of 11.97x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Tandem Diabetes Care, Inc. has a price-to-sales ratio of 1.50x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue